Skip to main content
The Phosphate Company Limited logo

The Phosphate Company Limited — Investor Relations & Filings

Ticker · 542123 ISIN · INE398C01016 LEI · 335800YQQ8XKWYSIQ472 BSE.NS Manufacturing
Open in API
Filings indexed 5 across all filing types
Latest filing 2026-05-27 Regulatory Filings
Country IN India
Listing BSE.NS 542123

About The Phosphate Company Limited

https://www.phosphate.co.in/

The Phosphate Company Limited specializes in the manufacturing of fertilizers and industrial chemicals. Its core product portfolio includes Single Super Phosphate (SSP), a key nutrient source for agricultural soil enhancement. The company also produces Sulphuric Acid and Alumina Ferric, which are utilized across various industrial sectors. Established with a focus on chemical processing, the organization manages integrated facilities for the conversion of raw materials into agro-inputs and chemical products. Its operations support agricultural productivity by providing essential phosphorus-based fertilizers and serve industrial requirements through the supply of basic chemicals. The company maintains a focus on quality standards and technical expertise in the production of chemical compounds for both soil health and industrial applications.

Recent filings

Filing Released Lang Actions
Newspaper publication
Regulatory Filings Classification · 88% confidence The document is a letter from The Phosphate Company Limited to the BSE and CSE under Regulation 30 of the Listing Regulations. It notifies the exchanges of the submission of newspaper clippings of the financial results for the year ended 31 March 2026, which were approved at the Board meeting on 25 May 2026 and published on 27 May 2026. The letter does not itself present the financial statements or detailed results; it merely transmits the newspaper clipping as a compliance notification. This is a routine regulatory announcement under listing rules rather than an earnings release, full annual report, or management commentary. It therefore falls under the general regulatory filings category (RNS).
2026-05-27 English
Outcome of Board Meeting
Regulatory Filings Classification · 86% confidence The document is a disclosure under SEBI LODR Regulation 30 notifying exchanges of the outcome of a Board meeting (approval of results and dividend recommendation) without providing the full financial statements. It is not the full report itself but a regulatory announcement. Therefore it falls under the generic Regulatory Filings (RNS) category.
2026-05-25 English
31-03-2026
Interim / Quarterly Report Classification · 90% confidence The document is a regulatory filing under SEBI Listing Regulation 33: it contains the Board’s approval of and the Statutory Auditor’s report on the Audited Financial Results for the quarter and year ended March 31, 2026, followed by detailed actual financial statements (statement of financial results with balance sheet, cash flows, segment reporting, and auditor’s opinion). This goes well beyond a mere announcement or press release and is not a full annual report, but rather the comprehensive audited quarterly (and year-to-date) results filing. Therefore, it best fits the Interim / Quarterly Report category. FY 2026
2026-05-25 English
The Phosphate Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2026 ,inter alia, to consider and approve 1. Approval of Audited ....
Regulatory Filings Classification · 85% confidence The document is a stock exchange intimation under SEBI (LODR) Regulations announcing the adjournment and reconvening of a Board Meeting to consider audited financial results and recommend a final dividend. It does not contain the actual audited results, dividend declaration, nor is it a change in management or similar. This is a regulatory announcement/filling under Listing Obligations, fitting the Regulatory Filings (RNS) category as a general compliance communication.
2026-05-20 English
The Phosphate Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2026 ,inter alia, to consider and approve To consider inter-alia ....
Regulatory Filings Classification · 82% confidence The document is a short notice to stock exchanges informing them of the rescheduling of a board meeting date. It contains no financial data, no report attachment, and no change in board composition or management. It is a routine regulatory announcement to comply with exchange disclosure requirements. Therefore, it falls under the general regulatory filings category (RNS).
2026-05-12 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.